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INTRODUCTION
The field of epigenetics is currently garnering a great deal of interest, exploring 
how our very molecular makeup in the form of modifications to the genome can be 
altered by factors as diverse as aging, disease, nutrition, stress, alcohol, and exposure 
to pollutants. Epigenetic changes have previously been implicated in the etiology of 
a variety of diseases [1], notably in the development of certain cancers [2], and inher-
ited growth disorder syndromes [3], but the exploration of epigenetics’ role in fetal 
programming is still in its infancy. This chapter focuses on how nutritional expo-
sures during pregnancy may affect the infant epigenome, and the impact that such 
modifications may have on the long-term health of the child. We start by describing 
some keys concepts in epigenetics and discuss windows of epigenetic plasticity in 
the context of the developmental origins of health and disease (DOHaD) hypoth-
esis. We then review some of the key mechanisms by which nutrition can affect the 
epigenome, with a particular focus on the role of one-carbon metabolism. We finish 
by outlining some of the child health outcomes that have been linked to epigenetic 
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dysregulation, and discuss possible next steps that need to be realized if insights 
into the basic science of epigenetics are to be translated into tangible public health 
benefits.
A BRIEF PRIMER ON EPIGENETICS
Epigenetic processes describe changes to the genome that can alter gene expression 
without changing the underlying DNA sequence [4]. These changes are mitotically 
heritable, and involve the interplay of DNA methylation, histone modifications, and 
RNA-based mechanisms (Figure 22.1). DNA methylation most commonly occurs 
at loci where a cytosine is found next to a guanine on a DNA strand along its linear 
sequence, hence termed cytosine-phosphate-guanine or CpG sites. It involves the 
covalent bonding of a methyl (CH3) group to the cytosine at the 5′ carbon position 
to form 5-methylcytosine. CpGs found in high densities are termed CpG islands. 
Roughly two-thirds of human genes contain CpG islands in their promoter regions, 
although repetitive elements in the genome can also contain many CpG sites [5]. 
CpGs are generally methylated in nonpromoter regions and unmethylated at pro-
moter regions. Methylation at CpG sites in promoters is usually associated with tran-
scriptional silencing, although not consistently [6]. Although methylation is the most 
studied chemical alteration to date, others modifications (e.g., hydroxymethylation) 
can occur at cytosine bases [7].
DNA methylation is catalyzed by DNA methyltransferases (DNMTs). Mammals 
have three types of DNMT. DNMT1 recognizes hemimethylated DNA; therefore, 
after DNA replication and cell division, it methylates the newly synthesized strand to 
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FIGURE 22.1 An overview of epigenetic mechanisms. (From Yan MS-C, Matouk CC, 
Marsden PA, J Appl Physiol 2010, 109:916–26.)
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maintain methylation patterns of the original template strand (maintenance methyla-
tion). DNMT3a and 3b appear to primarily methylate fully unmethylated CpG sites 
(de novo methylation) [7]. DNA methylation is important for a host of biological 
processes, including transcriptional silencing, X-chromosome inactivation, genomic 
imprinting, and the maintenance of cellular identity by enabling tissue-specific gene 
expression [8].
DNA is tightly woven around histone proteins, forming compact complexes of 
DNA and protein called nucleosomes. Nucleosomes, in turn, are packed together 
to form chromatin. Within the nucleosomes, the histone proteins are arranged in an 
eight-part formation, comprising two copies each of histones H2A, H2B, H3, and 
H4. Histone modifications involve various posttranslational chemical alterations to 
the amino acids of the histone tails, including acetylation of lysine, methylation of 
lysine and arginine, phosphorylation of serine and threonine, and the ubiquitination 
of lysine [9]. There are several mechanisms by which chemical modifications of 
CpG sites and histones are thought to influence gene expression. The methyl group 
from 5-methylcytosine may block transcription factors either directly or through the 
recruitment of a methyl-binding protein. Alternatively, the DNMT enzymes acting 
on CpG sites may be physically linked to other enzymes, which bring about histone 
methylation and deacetylation [10]. Although chromatin remodeling is intricately 
controlled, a simplified summary is that the hyperacetylation of histones and hypo-
methylation of histones and CpGs is associated with a euchromatin (open) configu-
ration, generally associated with facilitation of transcriptional activity. Conversely, 
hypoacetylation of histones and hypermethylation of histones and CpGs is associ-
ated with a heterochromatin (closed) structure and transcriptional repression [11].
Although noncoding RNAs do not code for proteins, many are functional and 
may affect gene expression [12]. Of those that influence gene expression, microRNAs 
(miRNAs) have been the most studied to date. These are short pieces (~22 nucleo-
tides) of RNA that affect the epigenome through binding to target mRNAs control-
ling the expression of key regulators such as DMNTs and histone deacetylases [13]. 
In turn, CpG methylation and histone modifications can influence the transcription 
of certain miRNA classes [14]. MicroRNAs may also affect gene expression directly 
by binding to messenger RNAs, repressing their translation [14].
TIME POINTS OF PLASTICITY IN THE EPIGENOME
Times of increased cell turnover, such as during fetal development and infancy, may 
be particularly susceptible both to epigenetic errors and to environmental influences 
[15]. In this chapter, we focus on DNA methylation and the in utero period, to include 
periconception, since this falls within the first 1,000 days window, and is also a 
period of exceptionally rapid cell differentiation and complex epigenetic remodeling 
(Figure 22.2). In the first 48 hours after fertilization, there is rapid (active) demeth-
ylation of the paternal genome and a slower (passive) demethylation of the mater-
nal genome [16]. Erasing the epigenetic marks in the zygote prior to the blastocyst 
stage is important to enable pluripotency of the developing cells [8]. Imprinted genes 
and some retrotransposons (defined later) are known to resist demethylation at this 
stage [17]. Remethylation then occurs in tissue-specific patterns after implantation, 
338 The Biology of the First 1,000 Days
during the process of gastrulation and differentiation of the somatic cells through-
out pregnancy. A second wave of demethylation occurs during the epigenetic repro-
gramming of primordial germ cells (PGCs) in the developing embryo at the point of 
their migration to the genital ridge [18]. Parental imprints are erased at this stage in 
preparation for the laying down of sex-specific imprints in the PGCs. Remethylation 
of sperm cells occurs before the birth of the child, and in oocytes over the duration 
of their maturation [18]. The periconceptional period is therefore one of huge dyna-
mism in the methylome, representing a window in which epigenetic errors could 
have significant consequences for the health of the child.
Which Parts of the ePigenome are most suscePtible 
to environmental influences?
There are some regions of the genome that demonstrate increased interindividual 
epigenetic variation, and may be particularly vulnerable to the impact of environ-
mental influences [19]. These include imprinted genes, metastable epialleles, and 
transposable elements. Imprinted genes show monoallelic expression, whereby only 
the maternally or paternally inherited allele is expressed [20]. If a gene is “paternally 
expressed” it means the expressed allele comes from the father and the maternal 
allele is imprinted (silenced). In regard to growth, paternally expressed genes tend 
to promote in utero growth, whereas maternally expressed genes restrict growth, 
and this forms the basis of the “parental conflict theory” [21]. Metastable epial-
leles (MEs) are genomic loci whose methylation state varies between individuals, 
but where variation is correlated across tissues originating from all germ layers in a 
single individual [22]. This indicates that the marks have been laid down in the first 
few days after conception before cell types start to specialize. MEs therefore provide 
a useful device to study the influence of the periconceptional environment, including 
maternal nutrition, on the offspring epigenome [23,24]. Transposable elements (TEs) 
are small pieces of DNA (usually of viral origin earlier in human history) that are 
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FIGURE 22.2 Epigenetic remodeling in embryogenesis. (From Perera F, Herbstman J, 
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mobile and can insert into new chromosomal locations throughout the genome. They 
are thought to make up more than half of the human genome [25]. TEs arise either 
through the use of RNA as an intermediate for transposition (DNA is transcribed to 
RNA, reverse transcribed to DNA, and then inserted by reverse transcriptase to form 
a retrotransposon), or through the complete DNA sequence being cut and pasted 
directly (forming DNA transposons, which are less common in the human genome). 
TEs are potentially functionally disruptive, for example, if transposed into a func-
tional gene or when increasing copy number, and this may be one reason why most 
are silenced epigenetically [26]. Some TEs are thought to be vulnerable to the influ-
ence of nutrition at key time points [27], and their variable methylation patterns have 
been shown to affect neighboring gene expression, most notably in the Agouti mouse 
experiments detailed later in this chapter.
EPIGENETICS AND THE DEVELOPMENTAL 
ORIGINS OF HEALTH AND DISEASE
The DOHaD hypothesis describes the idea that environmental insults experienced 
early in life can increase the risk of adverse health outcomes throughout the life 
course. DOHaD grew out of David Barker’s seminal work following a cohort born in 
Hertfordshire between 1911 and 1930. His early studies found an inverse relationship 
between birth weight and blood pressure at age 10, with a stronger association at age 
36 [28]. His findings soon expanded to identifying associations between low birth 
weight and adult-onset chronic disease [29], patterns that were also seen in different 
cohorts such as the Nurses’ Health Study I & II [30] and in Helsinki [31].
Although low birth weight provides a useful proxy for an adverse intrauterine 
environment, subsequent studies have attempted to pinpoint time points of vulner-
ability more precisely. Data from famine studies have been particularly useful in this 
respect. The Dutch Hunger Winter occurred toward the end of World War II, when 
the Western Netherlands was under German control from November 1944 to May 
1945. Nazi blockades cut off food and fuel, and the siege was coupled with a harsh and 
early winter. Calorie intake varied from 500 to 1,000 kcal per day, depending on the 
area and time period. An estimated 4.5 million people were affected, 20,000 of whom 
died [32]. Exposure to famine during pregnancy has been associated with a wide 
range of offspring phenotypes, from lower birth weight [33] to increased adult blood 
pressure [34], obesity [35], and risk of schizophrenia [36]. Furthermore the specific 
timing of famine exposure in utero appears to have different programming effects. 
For example, exposure in midgestation is associated with a doubling of the prevalence 
of obesity for men aged 18 to 19, yet exposure in the third trimester is associated with 
lower obesity [35]. Many of these associations are also found from records spanning 
the Chinese Great Leap Forward, where famine was particularly severe from 1959 
to 1961. For example, famine exposure in utero is associated with a doubled risk of 
schizophrenia in later life [37], as well as increased hyperglycemia at age 41 to 42, a 
trend that is exacerbated if an affluent diet was consumed later in life [38].
Although these two famine studies provide rich epidemiological evidence that 
nutritional exposures in early life are associated with later disease risk, they are 
unable to determine precise causal factors, for example, if the effects are driven by 
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depleted maternal energy, deficient levels of certain micronutrients, or a combination 
of both. The Pune Maternal Nutrition Study (PMNS) in the Maharashtra State of 
West-Central India sheds some light on more specific nutritional exposures that may 
be relevant for DOHaD mechanisms. PMNS is a prospective cohort of 797 women, 
followed pre- and throughout pregnancy, and their offspring. Higher maternal intake 
of green leafy vegetables, milk, and fruit, and higher erythrocyte folate concentra-
tions, were associated with larger size babies [39]. Higher maternal folate status at 
28 weeks gestation predicted higher offspring adiposity and insulin resistance at the 
age of 6, low maternal vitamin B12 status was associated with offspring insulin resis-
tance, and a combination of high maternal folate and low B12 produced the strongest 
associations [40].
Attention is now shifting to an investigation of the mechanisms that may mediate the 
observations above. In this respect, epigenetic modifications to the genome are emerg-
ing as a leading candidate that may, at least partially, explain some of the observations 
described in the DOHaD literature. For example, Heijmans et al. selected 60 individu-
als conceived during the Dutch Hunger Winter, and compared them with nonexposed 
siblings. Five CpG sites within IGF2 (a maternally imprinted gene controlling fetal 
growth) were less methylated in individuals exposed to famine at periconception, but 
there was no difference in methylation for individuals exposed to famine in late gesta-
tion [41]. Indeed, the most recent study from the same group confirms that exposure to 
famine in the first 10 weeks of gestation shows a greater signature in the adult blood 
methylome (58–59 years) compared to exposure later in gestation [42]. Whilst the exact 
mechanisms are so far unknown, one concept being debated is the “thrifty epigenome” 
hypothesis. This proposes that early life insults mold an epigenetic signature to pro-
gram a phenotype that is “adapted” to the intrauterine environment, which may be prob-
lematic if the environment into which the child is born then changes [43]. Under this 
hypothesis, malnutrition in pregnancy could program “thrifty” epigenotypes, designed 
to reduce metabolic rate and store energy in an attempt to adapt to a nutritionally poor 
environment, but may subsequently trigger symptoms of metabolic disease if the envi-
ronment changes to one of relative nutritional abundance.
MATERNAL NUTRITION EXPOSURES AND THE INFANT EPIGENOME
There are a variety of factors, both nutrition-related and otherwise, which may impact 
the infant epigenome in utero through maternal exposure (Figure 22.3). Of these 
exposures, particular attention has been paid to the role of one-carbon metabolites in 
the periconceptional period and during embryonic development [44]. In the follow-
ing section, we give an overview of one-carbon metabolism, and discuss evidence 
for the influence of one-carbon metabolites on the infant epigenome. We also briefly 
review other maternal nutrition exposures that have generated research in a human 
intergenerational setting: maternal BMI, polyunsaturated fatty acids, and vitamin C.
one-carbon metabolism
The one-carbon pool is composed of one-carbon units and the two main carriers that 
activate, transport, and transfer these units: tetrahydrofolate (THF) and S-adenosyl 
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methionine (SAM). One-carbon units are used as substrates for a whole range of 
intricate biochemical processes, including cellular biosynthesis, redox status regula-
tion, and genome maintenance through the regulation of nucleotide pools. However, 
it is their role in transmethylation reactions that is central to the notion of diet-
epigenome interplay, and this requires an understanding of how folate, methionine, 
homocysteine, transsulfuration, and transmethylation metabolic pathways interact 
(Figure 22.4).
S-adenosyl methionine (SAM) methylates a wide variety of acceptors in reactions 
catalyzed by methyl transferases. Over 200 methylation reactions are required for 
transcription, translation, protein localization, and signaling purposes [45], but it is 
the methylation of cytosine bases and amino acids on histone tails that play a role in 
epigenetics. The donation of SAM’s methyl group forms S-adenosyl homocysteine 
(SAH), which is further hydrolyzed to homocysteine (Hcy), where it is maintained in 
an equilibrium state that thermodynamically favors SAH over Hcy [46]. A buildup 
of Hcy results in an increase in SAH, which in turn impedes methylation reactions 
since SAH competes with SAM for the active site on methyl transferase enzymes 
[47]. The SAM:SAH ratio is therefore often used as a proxy indicator of methyla-
tion potential [48]. In order to maintain favorable methylation conditions, Hcy has 
to be removed from the system. One way in which this can happen is by accepting a 
methyl group to form methionine, which can then in turn be condensed with ATP to 
form SAM and continue the cycle. Hcy can also be removed through its irreversible 
degradation to cystathionine and cysteine in the transsulfuration pathway requiring 
vitamin B6.
The methylation of Hcy to methionine uses two distinct pathways. The major 
pathway is the vitamin B12-dependent reaction involving folate metabolic pathways. 
A stepwise reduction of dietary folates and folic acid forms tetrahydrofolate (THF). 
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FIGURE 22.3 Potential maternal factors impacting the fetal epigenome.
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The one-carbon units attach to the N5 or N10 position, or bridge the two. THF can be 
converted into N5,10-methylene-THF using a methyl group primarily from serine with 
vitamin B6 as a cofactor. N5,10-methylene-THF is either used in the thymidylate syn-
thase pathway for DNA synthesis and repair, interconverted to N5,10-methenyl-THF, 
N10-formyl-THF (used in purine synthesis) and formate (an important one-carbon 
donor) forms, or irreversibly reduced to N5-methyl tetrahydrofolate (methyl-THF) 
through the action of 5,10-methylene THF reductase (MTHFR) and vitamin B2 as a 
cofactor. It is methyl-THF that then provides the methyl group for the methylation of 
Hcy, and in the process regenerates THF. The alternative pathway for the methyla-
tion of Hcy, predominantly used in the liver and kidneys, uses the methyl group from 
betaine, a product formed through the oxidation of choline. This description and 
Figure 22.4 give a very simplified overview of the complex and interlinking meta-
bolic pathways involved, some of which occur with different enzymes in different 
cellular compartments [49]. However, this brief overview helps explain why deficien-
cies in the key methyl donors of choline, betaine, or folate, alongside deficiencies 
in vitamins B2, B6, and B12, which play essential coenzyme roles, may disrupt the 
metabolic pathways that are responsible for DNA methylation. Genetic variants in 
proteins coding for enzymes used in key one-carbon metabolic processes can also 
affect activity at critical nodes and alter the flow of metabolites [50].
studies investigating one-carbon metabolites and ePigenetics
Perhaps the most famous animal experiments demonstrating how epigenetic changes 
driven by maternal diet in pregnancy can dramatically alter phenotype in the off-
spring come from the agouti mouse. In one experiment, pregnant dams were fed a 
diet that varied in methyl donor content (folic acid, choline, betaine, and vitamin 
B12). Their isogenic pups showed variable methylation at an intracisternal A particle 
(IAP), a retrotransposon upstream of the agouti gene that is a metastable epiallele. 
The degree of methylation at this locus altered expression of the agouti gene, result-
ing in permanent phenotypic differences. The most obvious change was in fur color, 
but differences were also found in appetite, adiposity, and glucose tolerance, factors 
highly relevant to life-long chronic disease risk [19,27]. A similar experiment in a 
different strain of kinky-tailed mice showed that methyl donor content of the mater-
nal diet also altered methylation at an IAP on the Axin gene, producing pups with 
varying levels of tail kink [51].
Human studies exploring associations between individual one-carbon metabolites 
and epigenetic effects are few and far between, especially those involving an inter-
generational study design. Homocysteine and vitamin B6 are two examples that are 
described in human cross-sectional studies assessing immediate effects on health at 
one time point within a single generation. Hyperhomocysteinemia has been associated 
with hypomethylation in several studies [52] supporting the hypothesis that epigenetic 
mechanisms may play a partial role in observed associations between hyperhomocys-
teinemia and decreased cardiovascular health via inflammation, free radical forma-
tion, and atherogenesis [53]. Low vitamin B6 levels may decrease N5,10-methenyl-THF 
through reduced serine hydroxymethyltransferase (SHMT) activity (Figure 22.4), 
stressing the thymidylate synthase pathway for DNA repair and incorporating more 
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uracil into DNA. This reduces genome stability through increased chromosome breaks, 
which, in turn, have been associated with increased levels of global DNA hypomethyl-
ation alongside a putative increased risk of tumor development [54].
Of the human studies using an intergenerational design, folate, vitamin B12, and 
choline have been most frequently investigated. Due to its role in preventing neural 
tube defects and involvement in some cancer therapies, folic acid has been extensively 
reviewed [55]. Increased periconceptional folic acid consumption has been associated 
with increased methylation in infants at a differentially methylated region (DMR) of 
the IGF2 gene, although these associations have not been established consistently [56]. 
Additional studies have found that maternal folate levels in late pregnancy influence 
offspring methylation patterns in the imprinting control region of IGF2 [57] and also 
in the imprinting regulator ZFP57 [58]. Despite the timing of maternal folate mea-
surements, these findings support the importance of nutritional status around concep-
tion, since many DMRs appear to have their methylation pattern established prior to 
gastrulation [59]. There are fewer studies assessing the effect of maternal vitamin B12 
status on the infant epigenome. However, preliminary evidence suggests that mater-
nal vitamin B12 levels at first antenatal visit are inversely correlated with infant cord 
blood global methylation levels [60]. For choline, one intervention study investigated 
the effect of supplementing mothers in the third trimester with daily choline of 480 mg 
versus 930 mg [61]. Higher maternal choline intake was associated with increased 
methylation of CRH and NR3C1 promoter regions within fetal placental tissue.
The complex interlinking metabolic pathways involved in one-carbon metabo-
lism may be more appropriately investigated by exploring the joint effects of relevant 
methyl donors and coenzymes. Researchers in The Gambia have been exploring 
human diet–epigenome interactions by exploiting a natural experimental design, in 
which fluctuations in energy balance and maternal nutritional exposures display a 
distinct bimodal seasonal pattern. The Gambia experiences a rainy (“hungry”) sea-
son from July to September (Figure 22.5a), a planting season with increased energy 
expenditure, depleted food stores, and peaks of malarial and diarrheal diseases. 
The dry (“harvest”) season occurs from February to April (Figure 22.5b), when 
(a) (b)
FIGURE 22.5 The Gambian (a) rainy/“hungry” and (b) dry/harvest seasons in Keneba, 
West Kiang. (Photo by Andrew M. Prentice.)
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harvesting takes place, leading to improved food security. Despite overall house-
hold food stores being more replete in the dry season, the rainy season offers the 
increased availability of certain micronutrients made available from rain-fed green 
leafy vegetables. It has been known for several decades that Gambian children born 
during the rainy season are up to 10 times more likely to die prematurely in young 
adulthood than those born during the dry season [62]. However, the processes under-
lying these findings have yet to be fully delineated, and nutrition-related epigenetic 
regulation in early embryonic development is emerging as one plausible contributory 
mechanism. A recent study compared women conceiving in the peak of the dry and 
the peak of the rainy season [24]. Maternal periconceptional plasma concentrations 
of folate, vitamin B2, methionine, betaine, and the SAM:SAH and betaine:dimethyl 
glycine ratios were higher in the rainy season, and concentrations of vitamin B12, 
homocysteine, and SAH were lower. This suggested that the maternal metabolome 
during the rainy season contained higher concentrations of methyl donors and exhib-
ited a higher methylation potential than the dry season metabolome. Indeed, off-
spring of these rainy season conceptions had higher levels of CpG methylation at six 
MEs in peripheral blood monocytes compared to the offspring of those conceived in 
the dry season, with similar patterns in hair follicle DNA [24]. A subsequent study 
details the genome-wide search for MEs susceptible to the periconceptional environ-
ment using two independent approaches [63]. Both found VTRNA2-1 as their top hit, 
an imprinted gene that was also found to exhibit increased hypomethylation among 
Gambian offspring conceived in the dry season compared to the rainy season. Taken 
together, the results support the hypothesis that maternal nutrition during the peri-
conceptional period can impact the infant epigenome in humans and has triggered 
further research into the possible phenotypic consequences.
Polyunsaturated fatty acids
Several studies indicate that increased consumption of ω-3 PUFAs is associated with 
reduced homocysteine levels [64]. In the context of early life nutrition, maternal fatty 
acid intake influences infant fatty acid composition via placental transfer and breast 
milk, with maternal PUFA intake potentially affecting infant appetite control, neuroen-
docrine function, and metabolic programming [65]. Investigating whether one-carbon 
pathways and epigenetic mechanisms are involved is of increasing interest. In rodent 
models, providing a maternal diet with excess folic acid and restricted vitamin B12 
(designed to reflect the nutritional situation in much of rural India) is associated with 
increased maternal oxidative stress, lower level of offspring placental and brain doco-
sahexaenoic acid, and decreased placental global methylation [66]. However, maternal 
supplementation with PUFAs seems to partially ameliorate the disrupted one-carbon 
metabolism associated with this diet [67]. One potential mechanism is through PUFAs 
upregulating enzymes responsible for the methylation of homocysteine to methionine 
[68], which in theory could increase the SAM:SAH ratio and help overcome the impact 
of reduced MTHFR activity brought about by the restricted vitamin B12. An additional 
recent hypothesis describes how a decreased maternal PUFA intake may increase the 
availability of methyl groups for DNA methylation since there would be reduced PUFAs 
for phosphatidylcholine synthesis and therefore less demand for methyl groups for this 
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pathway. The disruption to the one-carbon pathways brought about by low PUFA lev-
els is thought to alter epigenetic programming of placental genes, increasing the risk of 
aberrant methylation in offspring and adverse pregnancy outcome [69]. Human evidence 
at the intergenerational level, however, is currently limited to a study by Lee et al. [70]. 
Here, mothers were given either 400 mg of ω-3 PUFA (n = 131) or placebo (n = 130) 
daily from approximately 18 weeks gestation to birth. Among mothers supplemented 
with PUFAs, there was increased global methylation (measured at LINE-1 repetitive ele-
ments) in offspring of mothers who smoked (n = 26 case, 26 control) [71], and increased 
offspring IGF2 promoter 3 methylation in preterm infants (n = 16 case, 20 control) [70].
body mass index
Maternal body mass index (BMI) shows some association with infant epigenetic pat-
terns [72]. However, it can be difficult to define exactly what BMI represents as an 
exposure, since it does not always correlate well with body composition [73] and is a 
proxy for a wide range of potential metabolic disorders [74]. In an intergenerational 
setting, both maternal underweight and overweight is associated with epigenetic pat-
terns in infant cord blood [72]. The mechanism by which BMI influences epigenetics 
is so far unknown. Although SAM has been shown to be independently, positively 
associated with fat mass in older adults, alongside a higher rate of converting methio-
nine into SAM in obese individuals, the absence of a rise in the SAM:SAH ratio 
means conclusions are hard to draw [75]. Paternal BMI may also be a relevant expo-
sure to consider, since neonates born to obese fathers in a U.S. study showed hypo-
methylation at some loci within imprinted genes (MEST, PEG3, NNAT), independent 
of maternal obesity [76].
vitamin c and demethylation
As outlined earlier, the periconceptional period is a time of widespread remodel-
ing of the offspring epigenome, including rapid erasure (demethylation) of paren-
tal epigenetic marks and subsequent remethylation (Figure 22.2). In demethylation, 
5-methylcytosine (5mC) can be sequentially oxidized to different states by ten-
eleven translocation (TET) dioxygenases that use vitamin C (ascorbate) as a cofac-
tor [77]. In vitro studies, for example, indicate that adding vitamin C to mouse or 
human embryonic stem cells increases activity of TET enzymes, with active demeth-
ylation seen in the germline and associated gene expression changes [78]. Vitamin C is 
therefore  an  important factor to consider in epigenetic processes during early 
embryogenesis, although in vivo studies will be required to explore whether vitamin C 
deficiency could play a role in aberrant demethylation.
In this section we have identified some of the key ways that maternal nutrition 
might influence the offspring epigenome. Other exposures, both nutrition-related 
and otherwise, may also be involved. These include maternal stress [79], toxin expo-
sure [80], maternal hyperglycemia [81], the microbiome [82], dietary polyphenols 
[83], vitamin D [84], vitamin A [85], and infection [86]. As evidence builds, it will 
be necessary to explore how these multiple exposures work together to influence the 
347Epigenetics, Nutrition, and Infant Health
infant epigenome and to more clearly define the potential consequences for human 
health. It is to the latter point that we now turn.
PHENOTYPES ASSOCIATED WITH THE IMPACT OF MATERNAL 
EXPOSURES ON THE INFANT EPIGENOME
Most population-based epigenetic studies to date have been limited to exploring 
either associations between maternal exposures and infant epigenetic patterns, or 
between infant epigenetic patterns and later phenotypes. Evidence linking maternal 
exposure to infant phenotypes with epigenetics as a mediating mechanism is scarce.
The first category of associations, linking maternal exposures to infant epigen-
etic patterns, was reviewed earlier. A number of studies linking infant epigenetic 
patterns with later phenotypes have focused on imprinted genes as candidate loci, 
due to their role in fetal growth [17] and a range of diseases [3,20]. It has been sug-
gested that imprinted genes may be more vulnerable to the effects of epigenetic 
dysregulation, since epigenetic mechanisms underpin their monoallelic expression. 
On chromosome region 11p15.5 there are two imprinting control regions (ICRs) of 
interest: the H19/IGF2 domain (ICR1) and the KCNQ1/CDKN1C domain (ICR2). 
Hypomethylation of ICR1 and hypermethylation of ICR2 are associated with 
Russell-Silver syndrome (RSS; an undergrowth disorder), whereas hypermethylation 
of ICR1 and hypomethylation of ICR2 are associated with Beckwith-Wiedemann 
syndrome (BWS; an overgrowth disorder) [3]. In addition to the aberrant methylation 
found at ICR1 and ICR2, some studies suggest patients with RSS and BWS show 
methylation defects at multiple gene loci [87]. Evidence for associations between 
growth-related phenotypes (other than RSS and BWS) and methylation patterns at 
several imprinted gene loci is slowly accumulating. Other phenotypes investigated to 
date include intrauterine growth restriction [88], small for gestational age [89], birth 
weight [90] and later adiposity [91].
Several studies describe associations between maternal one-carbon metabolites 
and infant growth-related outcomes, for example, vitamin B12 [92], folate [93], and 
homocysteine [94]. What then is the evidence that these associations are mediated 
through epigenetic mechanisms? Preliminary evidence from the Dutch Hunger 
Winter, as described earlier, suggests that exposure to famine in pregnancy, particu-
larly around conception, is associated with differential methylation in genes linked to 
growth, and development [41], and that famine exposure is also related to a wide range 
of offspring cognitive health and cardiometabolic risk factors six decades later [95]. 
It is, however, difficult to establish the direction of causality, since disease states can 
also influence the epigenome [96]. This issue of reverse causality is particularly per-
tinent to studies using a retrospective cohort design. Stronger evidence comes from 
prospective cohorts, such as the Newborn Epigenetics Study (NEST) in the United 
States. Hoyo et al. describe a positive association between maternal folate levels in 
the first trimester and birth weight [90]. Increased maternal folate was also associated 
with increased methylation at MEG3, PLAGL1, and PEG3 in infant cord blood, and 
decreased methylation at IGF2. Five differentially methylated sites were associated 
with birth weight, and it was speculated that the association seen between maternal 
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folate and birth weight could be mediated by differential methylation at MEG3, H19, 
and PLAGL1. In a more recent study from the same cohort, McCullough et al. found 
maternal plasma concentrations of homocysteine in the first trimester were inversely 
associated with birth weight, particularly in males [97]. Children born to mothers 
with the highest quartile of plasma B12 showed lower weight gain between birth and 
3 years. However, only maternal vitamin B6 was positively associated with cord meth-
ylation at a DMR from MEG3. A further example comes from Godfrey et al., who 
found that higher methylation of RXRA and eNOS in umbilical cord tissue was asso-
ciated with offspring adiposity at age 9, and that higher RXRA methylation was also 
associated with lower maternal carbohydrate intake in early pregnancy [91].
Given the scarcity of existing data and the many potential confounders in cohort 
studies, there is not yet any clear consensus on the extent to which epigenetics is 
involved in the etiology of suboptimal growth, particularly in the more widely inves-
tigated phenotypes of IUGR and SGA [98]. Similarly, although prepregnancy folic 
acid supplementation is known to prevent neural tube defects, the extent to which 
this protection is epigenetically mediated is not yet clear [56]. In the next few years, a 
number of prospective cohort studies should shed further light on the links between 
early life exposures and phenotypes, mediated by epigenetic mechanisms. In the 
meantime, we can use the literature from the range of studies described earlier to 
speculate that periconceptional nutritional insults may influence epigenetic mecha-
nisms in the infant, causing disruption at multiple loci and potentially leading to a 
broad spectrum of phenotypic consequences in later life.
NEXT STEPS
The field of epigenetic epidemiology is in its infancy. Future challenges include the 
need to consider a much larger number of candidate genetic regions (a challenge that 
will be met as rapid improvements in technology facilitate epigenome-wide associa-
tion studies with ever increasing genomic resolution); the need to focus on tissue 
types most appropriate to the phenotype of interest; and the need to integrate data 
on genetic variation, gene expression, and other epigenetic mechanisms such as his-
tone modifications and miRNAs. Investigations will also need to assess the extent 
to which postnatal exposures may interact with periconceptional effects. Finally, 
although we focus on the maternal periconceptional environment in this chapter, 
there is growing interest in the potential for paternal exposures to affect the infant 
epigenome transgenerationally via sperm methylation profiles [99]. Despite limited 
human evidence to date, this is an area of great potential public heath relevance.
Once disrupted epigenetic patterns can be better mapped onto phenotypes, the signifi-
cance for public health impact becomes more tangible. Can we design and test nutritional 
interventions to “correct” a suboptimal maternal metabolome, hence reducing patterns 
of aberrant methylation in the infant epigenome and reducing the burden of ill health? 
Despite the current complexities of disentangling the web of multiple exposures influenc-
ing the infant epigenome, as technology advances, collaborations grow, and knowledge 
is gained, the field of nutritional epigenetics has the potential to impact the health of 
children not only within the first 1,000 days but also across multiple generations.
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